Zhou Y, Zhou B, Ke X, Ma Y, et al. Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study. Acta Diabetol 2025 Aug 1. doi: 10.1007/s00592-025-02571.
PMID: 40748365